|
GB0622190D0
|
|
Oncolytic viruses
|
|
GB0622191D0
|
|
Viruses for immune modulation
|
|
AU2006200203A1
|
|
Herpes viruses for immune modulation
|
|
GB0522684D0
|
|
Oncolytic viruses
|
|
GB0522683D0
|
|
Viruses for immune modulation
|
|
GB0522476D0
|
|
Oncolytic herpes virus vectors
|
|
US2004063094A1
|
|
Mutant herpes simplex viruses and uses thereof
|
|
GB0317511D0
|
|
Viral vectors
|
|
US2003219409A1
|
|
Eukaryotic gene expression cassette and uses thereof
|
|
US2004022812A1
|
|
Herpes viruses for immune modulation
|
|
GB0118403D0
|
|
Expression cassette
|
|
US6713067B2
|
|
Herpes viruses for immune modulation
|
|
BRPI0107736B1
|
|
strain hsv1 js1 pharmaceutical composition and use of a strain hsv1 js1
|
|
GB0100430D0
|
|
Virus strains
|
|
GB0100288D0
|
|
Virus strains
|
|
AU8548198A
|
|
Use of transcription factor brn-3a
|
